Medindia

X

Encision Reports Profitable Fourth Quarter and Fiscal Year 2011 Results

Wednesday, June 1, 2011 General News J E 4
Advertisement

Encision Inc.

Condensed Statements of Operations

(Amounts in thousands, except per share information)

(Audited)

Three Months Ended

Fiscal year Ended

March 31, 2011

March 31, 2010

March 31, 2011

March 31, 2010

Net sales

$ 2,921

$ 3,186

$ 11,617

$ 12,836

Cost of sales

1,207

1,305

4,404

4,969

Gross profit

1,714

1,881

7,213

7,867

Operating expenses:

 Sales and marketing

1,017

1,178

4,242

4,758

 General and administrative

324

405

1,457

1,464

 Research and development

328

392

1,464

1,339

  Total operating expenses

1,669

1,975

7,163

7,561

Operating income (loss)

45

(94)

50

306

Interest and other income (expense), net

(10)

0

(45)

(41)

Income before provision for income taxes

35

(94)

5

265

Provision for income taxes

––

––

––

––

Net income (loss)

$     35

$   (94)

$       5

$    265

Net income per share—basic and diluted

$   0.01

$ (0.01)

$   0.00

$    0.04

Basic weighted average number of shares

6,455

6,455

6,455

6,455

Diluted weighted average number of shares

6,464

6,455

6,465

6,464

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
BioDelivery Sciences Retains The Trout Group for I...
S
Reportlinker Adds China's Guidebook for Pharmaceut...